Navigation Links
Ambulatory Services of America, Inc. Announces Joint Venture to Operate Radiation Oncology Facility in Dallas, Texas
Date:7/2/2008

NASHVILLE, Tenn., July 2 /PRNewswire/ -- Ambulatory Services of America, Inc. announced the formation of ROSA of North Dallas, LLP, its sixth joint venture to provide outpatient radiation oncology services. ROSA of North Dallas is a joint venture between ASA's subsidiary, Radiation Oncology Services of America, and some of the former owners of Landmark Radiation Dallas LP. ROSA of North Dallas will own and operate Northpoint Cancer Center in Dallas, Texas, which was previously owned and operated by Landmark Radiation Dallas.

(Logo: http://www.newscom.com/cgi-bin/prnh/20071218/CLTU087LOGO)

ROSA of North Dallas will offer state-of-the-art cancer treatment services, including intensity-modulated radiation therapy (IMRT) and image-guided radiation therapy (IGRT) in the Dallas center. The joint venture expects to build on Landmark Radiation's legacy of providing high-quality cancer care to the residents of the north Dallas area. Edward Gilbert, M.D. will serve as medical director for ROSA of North Dallas, and Dr. Timothy Nichols will also continue to provide professional radiation oncology services at the facility.

Dr. Gilbert said, "We look forward to working with Ambulatory Services of America and Radiation Oncology Services of America to provide a full range of radiation therapy services to patients in North Dallas. We are pleased to have worked with Landmark Radiation to build the North Dallas center and look forward to a long relationship with ASA and ROSA."

Timothy Martin, President and Chief Executive Officer of ASA, said, "We are excited to expand our presence in the Dallas area and Texas generally. With the formation of ROSA of North Dallas, we now own and operate three radiation oncology centers in Texas, with two in the Dallas metropolitan area. We look forward to working with our new affiliated physicians to provide high quality care to cancer patients."

Ambulatory Services of America, headquartered in Brentwood, Tennessee, is a diversified health care services company that provides alternative site services in partnership with physicians. ASA, through its primary subsidiaries Radiation Oncology Services of America, Inc. and Renal Services of America, Inc. owns, operates and manages facilities providing radiation oncology services and dialysis services. After the acquisition, ASA will own interests in and operate 41 dialysis centers and 13 radiation oncology centers in nine states and the territory of Guam. ASA also manages three other dialysis centers.


'/>"/>
SOURCE Ambulatory Services of America, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. Ambulatory oxygen rarely a benefit in COPD patients without resting hypoxemia
2. PainCare Receives $14.4 Million in Cash From Completed Sale of South Florida Ambulatory Surgery Centers
3. Medicare Prescription Drug Benefit, Nonprofit Hospitals, Ambulatory Surgery Centers, Statistical Methods, and Pay-For-Performance Highlighted In the Latest INQUIRY Journal
4. Ambulatory Services of America, Inc. Announces Joint Venture with Southern Ocean County Radiation Oncology, LLC
5. Reproductive Science Center of New England Receives Ambulatory Health Care Accreditation
6. Ambulatory Services of America, Inc. Announces Joint Venture With Denton Cancer Center, LP
7. Ambulatory Services of America, Inc. Announces Investment by Lindsay Goldberg
8. Lutheran Senior Services Partners with Silverchair Learning Systems to Enhance Employee Training and Education
9. GAO Report Confirms: Medicare Underpays for Anesthesia Services; Nurse Anesthetists Assure Seniors Access to Safe Anesthesia Care
10. Therap Services Continues to Hire Experienced Developmental Disability Industry Clinicians for its Customer Support Team
11. Tata Consultancy Services to Support Roches Global Capacity Building Initiative
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/27/2017)... (PRWEB) , ... February 27, 2017 , ... ... mass and overall body strength, which often leads to a host of health ... Journal of the American Geriatrics Society discovered that good overall muscle strength ...
(Date:2/27/2017)... ... February 27, 2017 , ... Robert E. Burke, MD, PhD, had ... his impoverished upbringing and life experiences could have led him down a much different ... Inspirational Tales of Parenting, Perseverance and Pediatrics,” Dr. Burke shares a personal account of ...
(Date:2/27/2017)... , ... February 27, 2017 , ... Much attention has ... for women who become dependent on opioid painkillers has fallen short. From 1999 until ... to a 237% increase in fatal overdoses in male populations.(1) , The proportion of ...
(Date:2/27/2017)... , ... February 27, 2017 , ... Elisa Guajardo Carothers is not your typical author. ... studying to become a nun. Now, she writes about God, when she isn’t swimming as ... BC and AD, Here is BS! (Before Satan),” she offers a comedic look at the ...
(Date:2/27/2017)... Yorba Linda, Ca (PRWEB) , ... February 27, ... ... Coulter Life Sciences, provides an overview on laser diffraction analysis as a tool ... highlighting its capabilities, significance and potential to obtain improved results and novel scientific ...
Breaking Medicine News(10 mins):
(Date:2/27/2017)... YORK , Feb. 27, 2017 /PRNewswire/ ... Michael P. Vallely , MBBS, PhD, FRACS, of  ... University of Sydney will be published ...  Journal of the American College of Cardiology ... "no-touch" beating heart bypass surgery technique (anOPCABG) ...
(Date:2/27/2017)... Feb. 27, 2017  International Biophysics Corporation, a global medical ... today announced a 34% revenue growth in 2016 when compared ... unit sales.  This growth was fueled by its AffloVest® sales ... to the expansion of its global sales of surgical product ... CEO, "As we enter our 25 th year in ...
(Date:2/27/2017)... , Feb. 27, 2017  RegeneRx Biopharmaceuticals, ... clinical-stage drug development company focused on tissue protection, ... for RGN-137, GtreeBNT Co., Ltd., received a positive ... 3 clinical trial design for RGN-137 to treat ... healing gel that incorporates Thymosin beta 4 ("Tß4") ...
Breaking Medicine Technology: